-
1
المؤلفون: Bo Ahrén, Hernando Vargas-Uricoechea, Elena Nikonova, Fernando Gomez-Peralta, Michael Krebs, Jean Francois Gautier, Gagik Radikovich Galstyan, Francesco Giorgino, William Stager
المصدر: Diabetes Therapy
مصطلحات موضوعية: endocrine system, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Lixisenatide, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Glucagon, Prandial, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glycemic control, Diabetes mellitus, Internal medicine, Post-hoc analysis, Type 2 diabetes mellitus, Internal Medicine, medicine, Glucagon-like peptide 1 receptor, business.industry, Brief Report, digestive, oral, and skin physiology, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, medicine.disease, Endocrinology, Postprandial, chemistry, Glucagon-like peptide-1 receptor agonist, Glycated hemoglobin, business, hormones, hormone substitutes, and hormone antagonists
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b305b8fec1c5651750bfb194d0a7c0bTest
-
2
المؤلفون: Michael A. Nauck, Murray Stewart, Rickey R. Reinhardt, Christopher Perkins, Fred Yang, Marc Rendell, Angela Jones-Leone, Caroline R Perry
المصدر: Diabetologia
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Placebo-controlled study, 030209 endocrinology & metabolism, GLP-1 agonist, Type 2 diabetes, 030204 cardiovascular system & hematology, Glucagon-Like Peptide-1 Receptor, Article, Albiglutide, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Glucagon-Like Peptide 1, law, Internal medicine, medicine, Clinical endpoint, Internal Medicine, Humans, Hypoglycemic Agents, Exercise, Glucagon-like peptide 1 receptor, Aged, Glycated Hemoglobin, Randomised controlled trial, business.industry, Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Glucagon-like peptide-1, Diet, Treatment Outcome, Diabetes Mellitus, Type 2, Physical therapy, Female, business, Biomarkers, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d957db1609d1ef586b8f87c52a9c3bTest
-
3
المؤلفون: Keith C. Ferdinand, Charles Atisso, Fady T. Botros, Philip T. Sager
المصدر: Cardiovascular Diabetology
مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, 0302 clinical medicine, Risk Factors, Clinical endpoint, Medicine, Myocardial infarction, Prospective Studies, Stroke, Original Investigation, Randomized Controlled Trials as Topic, Hazard ratio, Type 2 diabetes, Incretin, Middle Aged, Treatment Outcome, Cardiovascular Diseases, Female, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, Recombinant Fusion Proteins, 030209 endocrinology & metabolism, MACE, Risk Assessment, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, Cardiovascular events, 03 medical and health sciences, Internal medicine, Humans, Hypoglycemic Agents, Aged, Proportional Hazards Models, business.industry, Proportional hazards model, Unstable angina, Protective Factors, medicine.disease, Immunoglobulin Fc Fragments, Meta-analysis, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Dulaglutide, business, Mace, Biomarkers, Glucagon-like peptide-1 (GLP-1)
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03facb7cc158ef8edd4e179368bb1809Test